Abstract

Purpose To examine whether sociodemographic characteristics, access to care, risk behavior factors, and chronic health conditions were associated with colorectal cancer (CRC) screening utilization among breast, cervical, prostate, skin, and lung cancer survivors.

Methods We analyzed the 2020 Behavioral Risk Factor Surveillance System (BRFSS) data on 9780 eligible cancer survivors. Descriptive statistics and multivariable logistic regression models were applied to assess the association between guideline- concordant CRC screening and the mentioned characteristics.

Results Overall, 81.9%, 65%, 88%,78.1%, and 80.1% of breast, cervical, prostate, skin, and lung cancer survivors received CRC screening, respectively (p-value < 0.001). In multivariable analysis, breast, cervical, and skin cancer survivors aged 60 years or older were associated with higher odds of receiving CRC screening. Respondents that had their recency of routine checkup two or more years before had lower odds of having CRC screening among cervical (OR = 0.06; 95% CI, 0.02–0.22), prostate (OR = 0.26; 95% CI, 0.14–0.49), and skin cancer (OR = 0.50; 95% CI, 0.36–0.70) survivors. The presence of chronic diseases was also associated with guideline-concordant CRC screening among breast, prostate, and skin cancer survivors.

Conclusions Our findings provide important evidence on potential factors that are associated with guideline-concordant CRC screening utilization across different cancer survivors, which include older age, recency of routine checkup, and multiple chronic diseases. Moreover, variation in CRC screening utilization across cancer survivors may highlight missed opportuni- ties for secondary cancer prevention.

Implications for Cancer Survivors Establishing clear CRC screening guidelines and including patient-provider communica- tion on recommendation in cancer survivorship care may increase adherence to CRC screening.

Document Type

Article

Publication Date

10-10-2022

Notes/Citation Information

© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022

Digital Object Identifier (DOI)

https://doi.org/10.1007/s11764-022-01258-0

Funding Information

Justin X. Moore was supported by the National Institute on Minority Health and Health Disparities of the National Institutes of Health under Award Number K01MD015304. The content is solely the responsibility of the authors and does not necessarily rep- resent the official views of the National Institutes of Health. In addition, this research was supported at least in part through the Georgia Cancer Center Paceline funding mechanism (principal investigator: Meng-Han Tsai).

Download

Included in

Oncology Commons

Share

COinS